It has been reported that Fra-2 is a predicted transcription factor of cancer susceptibility candidate 9 (CASC9), an oncogenic lncRNA that further contributes to cell viability and proliferation of squamous NSCLC cells [61]. The gene discussed is FOSL2; the disease is non-small cell lung carcinoma.